Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 07-May-24 4:15 PM View:  | Allovir, Inc. (ALVR) | 03-May-24 | Sale | 4,957 | $0.80 | $3,945.77 | (< 1%) 17.81M to 17.81M | |
| 23-Apr-24 4:15 PM View: | Allovir, Inc. (ALVR) | 22-Apr-24 | Sale | 1,857 | $0.75 | $1,392.75 | (< 1%) 17.81M to 17.81M | |
| 23-Apr-24 4:15 PM View: | Allovir, Inc. (ALVR) | 19-Apr-24 | Sale | 1,521 | $0.75 | $1,141.66 | (< 1%) 17.82M to 17.81M | |
| 04-Apr-24 4:15 PM View: | Allovir, Inc. (ALVR) | 02-Apr-24 | Sale | 885 | $0.77 | $683.22 | (< 1%) 17.82M to 17.82M | |
| 22-Feb-24 4:15 PM View: | Allovir, Inc. (ALVR) | 20-Feb-24 | Sale | 2,893 | $0.70 | $2,011.21 | (< 1%) 17.82M to 17.82M | |
| 06-Feb-24 4:46 PM View: | Allovir, Inc. (ALVR) | 05-Feb-24 | Sale | 18,331 | $0.67 | $12,281.80 | (< 1%) 17.84M to 17.82M | |
| 25-Jan-24 4:15 PM View: | Allovir, Inc. (ALVR) | 23-Jan-24 | Sale | 3,205 | $0.67 | $2,149.91 | (< 1%) 17.84M to 17.84M | |
| 08-Jan-24 4:15 PM View: | Allovir, Inc. (ALVR) | 04-Jan-24 | Sale | 961 | $0.64 | $614.08 | (< 1%) 17.84M to 17.84M | |
| 21-Nov-23 5:00 PM View: | Allovir, Inc. (ALVR) | 17-Nov-23 | Sale | 2,490 | $1.63 | $4,061.44 | (< 1%) 17.84M to 17.84M | |
| 23-Oct-23 5:00 PM View: | Allovir, Inc. (ALVR) | 20-Oct-23 | Sale | 1,475 | $1.54 | $2,272.98 | (< 1%) 17.85M to 17.84M | |
| 23-Oct-23 5:00 PM View: | Allovir, Inc. (ALVR) | 19-Oct-23 | Sale | 1,232 | $1.58 | $1,946.56 | (< 1%) 17.85M to 17.85M | |
| 05-Oct-23 5:00 PM View: | Allovir, Inc. (ALVR) | 03-Oct-23 | Sale | 755 | $1.98 | $1,492.11 | (< 1%) 17.85M to 17.85M | |
| 21-Aug-23 5:00 PM View: | Allovir, Inc. (ALVR) | 17-Aug-23 | Sale | 10,516 | $2.50 | $26,242.70 | (< 1%) 17.86M to 17.85M | |
| 21-Jul-23 5:00 PM View: | Allovir, Inc. (ALVR) | 20-Jul-23 | Sale | 1,437 | $3.35 | $4,810.21 | (< 1%) 17.86M to 17.86M | |
| 21-Jul-23 5:00 PM View: | Allovir, Inc. (ALVR) | 19-Jul-23 | Sale | 1,198 | $3.56 | $4,266.68 | (< 1%) 17.86M to 17.86M | |
| 06-Jul-23 5:00 PM View: | Allovir, Inc. (ALVR) | 05-Jul-23 | Sale | 2,983 | $3.05 | $9,083.53 | (< 1%) 17.86M to 17.86M | |
| 21-Apr-23 4:05 PM View: | Allovir, Inc. (ALVR) | 20-Apr-23 | Sale | 1,466 | $3.63 | $5,314.98 | (< 1%) 17.86M to 17.86M | |
| 21-Apr-23 4:05 PM View: | Allovir, Inc. (ALVR) | 19-Apr-23 | Sale | 1,217 | $3.71 | $4,513.49 | (< 1%) 17.86M to 17.86M | |
| 03-Feb-23 5:00 PM View: | Allovir, Inc. (ALVR) | 02-Feb-23 | Grant | 157,500 | -- | -- | < 1% 17.7M to 17.86M | |
| 23-Jan-23 7:00 PM View: | Allovir, Inc. (ALVR) | 20-Jan-23 | Sale (Planned) | 1,426 | $5.14 | $7,335.06 | (< 1%) 17.71M to 17.7M | |
| 23-Jan-23 7:00 PM View: | Allovir, Inc. (ALVR) | 19-Jan-23 | Sale (Planned) | 5,111 | $5.08 | $25,952.10 | (< 1%) 17.71M to 17.71M | |
| 24-Oct-22 6:28 PM View: | Allovir, Inc. (ALVR) | 19-Oct-22 | Market Sale | 1,449 | $9.36 | $13,563.70 | (< 1%) 17.71M to 17.71M | (16%) |
| 17-Aug-22 6:04 PM View: | Allovir, Inc. (ALVR) | 16-Aug-22 | Grant | 100,000 | -- | -- | < 1% 17.61M to 17.71M | |
| 01-Aug-22 4:38 PM View: | Allovir, Inc. (ALVR) | 28-Jul-22 | Grant Duplicate | 3,253,800 | $4.61 | $15,000,000.00 | 23% 14.36M to 17.61M | |
| 21-Jul-22 7:12 PM View: | Allovir, Inc. (ALVR) | 20-Jul-22 | Sale | 1,432 | $5.21 | $7,467.16 | (< 1%) 14.36M to 14.36M | |
| 06-Jul-22 7:30 AM View: | Allovir, Inc. (ALVR) | 01-Jul-22 | Grant | 29,400 | -- | -- | < 1% 14.33M to 14.36M | |
| 22-Apr-22 8:29 AM View: | Allovir, Inc. (ALVR) | 20-Apr-22 | Sale | 1,162 | $6.68 | $7,767.16 | (< 1%) 14.33M to 14.33M | |
| 24-Jan-22 4:15 PM View: | Allovir, Inc. (ALVR) | 20-Jan-22 | Sale | 6,450 | $8.75 | $56,454.30 | (< 1%) 14.29M to 14.28M | |
| 04-Apr-22 4:25 PM View: | Allovir, Inc. (ALVR) | 18-Jan-22 | Grant | 48,838 | -- | -- | < 1% 14.28M to 14.33M | |
| 05-May-21 5:05 PM View: | Verona Pharma Plc (VRNA) | 04-May-21 | Sale (Planned) | 10,016 | $0.84 | $8,410.43 | (12%) 84.46K to 74.44K | |
| 03-Feb-21 7:11 PM View: | Verona Pharma Plc (VRNA) | 01-Feb-21 | Sale (Planned) | 10,224 | $0.99 | $10,160.60 | (11%) 94.68K to 84.46K | |
| 21-Jan-21 7:27 PM View: | Allovir, Inc. (ALVR) | 19-Jan-21 | Grant | 58,800 | -- | -- | < 1% 14.23M to 14.29M | |
| 05-Aug-20 9:57 PM View: | Allovir, Inc. (ALVR) | 03-Aug-20 | Conversion Duplicate | 13,421,000 | -- | -- | 1664% 806.6K to 14.23M | |
| 10-Aug-16 6:23 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 08-Aug-16 | Market Sale | 277 | $137.14 | $37,987.80 | (< 1%) 178.74K to 178.46K | (31%) |
| 01-Mar-16 6:33 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 29-Feb-16 | Market Sale | 1,122 | $138.91 | $155,862.00 | (< 1%) 179.86K to 178.74K | (30%) |
| 01-Mar-16 6:33 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 26-Feb-16 | Grant | 8,000 | -- | -- | 5% 171.86K to 179.86K | |
| 08-Feb-16 7:56 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 08-Feb-16 | Market Sale | 3,890 | $137.61 | $535,316.00 | (2%) 175.75K to 171.86K | (31%) |
| 08-Feb-16 7:56 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 05-Feb-16 | Market Sale | 1,954 | $143.50 | $280,404.00 | (1%) 177.71K to 175.75K | (25%) |
| 08-Feb-16 7:56 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 04-Feb-16 | Grant | 11,763 | -- | -- | 7% 166.65K to 178.41K | |
| 08-Feb-16 7:56 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 04-Feb-16 | Market Sale | 703 | $143.84 | $101,116.00 | (< 1%) 178.41K to 177.71K | (25%) |
| 05-Aug-15 6:08 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 04-Aug-15 | Market Sale | 675 | $196.52 | $132,651.00 | (< 1%) 167.32K to 166.65K | 8% |
| 03-Mar-15 9:13 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 02-Mar-15 | Market Sale | 487 | $180.34 | $87,825.60 | (< 1%) 167.81K to 167.32K | < 1% |
| 03-Mar-15 9:13 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 27-Feb-15 | Grant | 5,100 | -- | -- | 3% 162.71K to 167.81K | |
| 12-Feb-15 9:08 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 10-Feb-15 | Market Sale | 1,985 | $171.15 | $339,733.00 | (1%) 164.69K to 162.71K | (5%) |
| 09-Feb-15 8:48 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 09-Feb-15 | Market Sale | 2,703 | $174.18 | $470,810.00 | (2%) 167.4K to 164.69K | (3%) |
| 09-Feb-15 8:48 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 05-Feb-15 | Grant | 11,690 | -- | -- | 8% 155.71K to 167.4K | |
| 05-Feb-15 8:10 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 04-Feb-15 | Market Sale | 676 | $174.37 | $117,874.00 | (< 1%) 156.38K to 155.71K | (3%) |
| 05-Feb-15 8:10 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 03-Feb-15 | Market Sale | 895 | $174.06 | $155,784.00 | (< 1%) 157.28K to 156.38K | (3%) |
| 19-Dec-14 4:49 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 18-Dec-14 | Market Sale (Planned) | 5,493 | $182.08 | $1,000,170.00 | (3%) 162.77K to 157.28K | 1% |
| 04-Dec-14 5:20 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 03-Dec-14 | Option Exercise | 50,000 | $19.15 | $957,400.00 | 31% 162.77K to 212.77K |